UK places order for 60m doses of Sanofi/GSK’s COVID-19 vaccineThe UK government has signed its fourth coronavirus vaccine deal, snapping up 60 million doses of an experimental Share XUK places order for 60m doses of Sanofi/GSK’s COVID-19 vaccinehttps://pharmaphorum.com/news/uk-places-order-for-60m-doses-of-sanofi-gsks-covid-19-vaccine/
US places $1.95 billion order for Pfizer/BioNTech’s COVID-19 vaccineThe US government has agreed to pay Pfizer and BioNTech $1.95 billion to secure access to 100 million Share XUS places $1.95 billion order for Pfizer/BioNTech’s COVID-19 vaccinehttps://pharmaphorum.com/news/us-places-1-95-billion-order-for-pfizer-biontechs-covid-19-vaccine/
Moderna’s $37B market cap is too high, despite COVID-19 vaccine; analystJP Morgan has downgraded its valuation of Moderna, saying its $37 billion market cap is way too high Share XModerna’s $37B market cap is too high, despite COVID-19 vaccine; analysthttps://pharmaphorum.com/news/modernas-37b-market-cap-is-too-high-despite-covid-19-vaccine-analyst/
‘Promising’ data on Oxford/AZ, CanSino coronavirus vaccinesData from more than 1,000 healthy volunteers dosed with a coronavirus vaccine developed at Oxford University and AstraZeneca Share X‘Promising’ data on Oxford/AZ, CanSino coronavirus vaccineshttps://pharmaphorum.com/news/first-data-on-oxford-astrazeneca-cansino-coronavirus-vaccines-promising/
GSK-partnered Medicago starts trials of plant-based COVID-19 vaccineMedicago has started dosing healthy volunteers in the first human trial of its candidate vaccine for COVID-19, a Share XGSK-partnered Medicago starts trials of plant-based COVID-19 vaccinehttps://pharmaphorum.com/news/gsk-partnered-medicago-starts-trials-of-plant-based-covid-19-vaccine/
US snaps up first supplies of Regeneron’s COVID-19 antibodyHard on the heels of Regeneron moving its COVID-19 antibody cocktail into late-stage testing, the US government has Share XUS snaps up first supplies of Regeneron’s COVID-19 antibodyhttps://pharmaphorum.com/news/us-snaps-up-first-supplies-of-regenerons-covid-19-antibody/
CureVac claims €75m in EU funding for mRNA COVID-19 vaccineGerman vaccine firm CureVac has been awarded a €75 million loan from the European Investment Bank to boost Share XCureVac claims €75m in EU funding for mRNA COVID-19 vaccinehttps://pharmaphorum.com/news/curevac-claims-e75m-in-eu-funding-for-mrna-covid-19-vaccine/
Trial starts with Imperial College London coronavirus vaccineThe first healthy volunteer has been dosed with Imperial College London’s coronavirus vaccine, the second UK-developed candidate to Share XTrial starts with Imperial College London coronavirus vaccinehttps://pharmaphorum.com/news/trial-starts-with-imperial-college-london-coronavirus-vaccine/
AZ promises to deliver 400m doses of COVID-19 vaccine to EuropeAstraZeneca has followed through on its pledge to provide its COVID-19 vaccine at cost during the pandemic, saying Share XAZ promises to deliver 400m doses of COVID-19 vaccine to Europehttps://pharmaphorum.com/news/az-promises-to-deliver-400m-doses-of-covid-19-vaccine-to-europe/
